This one concerns use of valproate in pregnancy. UW says that a patient of bipolar disorder on a stable valproate dose should be switched to a drug less teratogenic. Does the same principle apply to epilepsy patients on valproate who become pregnant?
Because I remember reading that you maintain epileptic patients on the lowest effective dose of the same drug instead of initiating a new drug which could cause seizure relapse. Can anyone shed some light on this?
Because I remember reading that you maintain epileptic patients on the lowest effective dose of the same drug instead of initiating a new drug which could cause seizure relapse. Can anyone shed some light on this?